Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Current Oncology (Toronto, Ont.)|September 7, 2017
Exercise for people with cancer: a systematic reviewR Segal, C Zwaal, E Green, et al.
Techniques in Urology|May 8, 2000
Brachytherapy in patients with small prostate glandsD A Loblaw, K Wallner, S Dibiase, et al.
Current Oncology (Toronto, Ont.)|March 9, 2017
Exercise for people with cancer: a clinical practice guidelineR Segal, C Zwaal, E Green, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 17, 2021
Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: an Updated Systematic ReviewM A Haider, J Brown, X Yao, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 23, 1998
Re-irradiation for locally recurrent nasopharyngeal carcinomaM McLean, E Chow, B O'Sullivan, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 12, 2015
Accelerated hypofractioned postoperative radiotherapy for prostate cancer: a prospective phase I/II studyA Gladwish, A Loblaw, P Cheung, et al.
Current Oncology (Toronto, Ont.)|March 29, 2020
Complex surgery and perioperative systemic therapy for genitourinary cancer of the retroperitoneumA Finelli, N Coakley, J Chin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 20, 2007
Functional and pharmacokinetic outcomes after a single intravenous infusion of recombinant human erythropoietin in patients with malignant extradural spinal cord compressionD A Loblaw, L Holden, A Xenocostas, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 21, 2017
Follow-up Care for Survivors of Prostate Cancer - Clinical Management: a Program in Evidence-Based Care Systematic Review and Clinical Practice GuidelineA Loblaw, L H Souter, C Canil, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 1, 2022
Absolute Percentage of Pattern 4 Disease as a Prognostic Measure for Intermediate-risk Prostate Cancer Treated with Stereotactic Body RadiotherapyR M Glicksman, A U Kishan, H Quon, et al.
Pageof 5